Cargando…
Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes
Despite modern therapeutic advances, the survival prospects of pancreatic cancer patients have remained poor. Besides being highly metastatic, pancreatic cancer is challenging to treat because it is caused by a heterogeneous array of somatic mutations that impact a variety of signaling pathways and...
Autores principales: | Sinkala, Musalula, Mulder, Nicola, Martin, Darren Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044387/ https://www.ncbi.nlm.nih.gov/pubmed/30018740 http://dx.doi.org/10.18632/oncotarget.25632 |
Ejemplares similares
-
Machine Learning and Network Analyses Reveal Disease Subtypes of Pancreatic Cancer and their Molecular Characteristics
por: Sinkala, Musalula, et al.
Publicado: (2020) -
Integrated molecular characterisation of the MAPK pathways in human cancers reveals pharmacologically vulnerable mutations and gene dependencies
por: Sinkala, Musalula, et al.
Publicado: (2021) -
Metabolic gene alterations impact the clinical aggressiveness and drug responses of 32 human cancers
por: Sinkala, Musalula, et al.
Publicado: (2019) -
Proteogenomic analysis of pancreatic cancer subtypes
por: Kafita, Doris, et al.
Publicado: (2021) -
Mutational landscape of cancer-driver genes across human cancers
por: Sinkala, Musalula
Publicado: (2023)